Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradetrusor Botox for OAB: 1 vs 10 Injections
NCT05308979Phase 4Completed
- Sponsor
- University of California, Irvine
- Start
- May 2022
- Primary completion
- Dec 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in overactive bladder (OAB), Urinary urge incontinence (UUI), sponsored by University of California, Irvine. Started May 2022; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
overactive bladder (OAB)Urinary urge incontinence (UUI)
Beyond the preview
Go deeper on NCT05308979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05308979.